Clinical TrialID 5313

Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea

NCT01659853

Erythema|Rosacea

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
5313
Evidence Id
5313
Core Evidence Id
5313
Source Clinical Trial Id
5298
Herb2 Clinical Trial Id
HBCT005298
Nct Id
NCT01659853
Title
Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea
Status
Completed
Phase
Phase 3
Study Result
Yes
Study Condition
Erythema|Rosacea
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Intervention
DRUG: CD07805/47 gel 0.5%/CD07805/47 Vehicle|DRUG: azelaic acid gel 15%
Intervention Allocation
Randomized
Intervention Model
Crossover
Intervention Mask
Quadruple
Intervention Purpose
Treatment
Gender
All
Age
Adult, Older_Adult
Enrollment
70
Outcome Measure
Composite Success, Composite Success, defined as a 2-grade improvement at 6 hours on both the clinician's and subject's erythema assessments at the end of each treatment period, Hour 6 on Day 15
Sponsor Collaborator
Galderma R&D
Funded By
INDUSTRY
Location
Hudson Dermatology, Evansville, Indiana, 47714, United States|Dermatology Specialists Research, LLC, Louisville, Kentucky, 40202, United States|DermResearch, Inc, Austin, Texas, 78759, United States|The Education & Research Foundation, Inc., Lynchburg, Virginia, 24501, United States
Other Id
US10219
Start Date
2012-09
Primary Completion Date
2012-12
Completion Date
2012-12
First Posted
2012-08-08
Results First Posted
2014-07-10
Last Update Posted
2022-08-25
Study Document
Study Url
https://clinicaltrials.gov/study/NCT01659853
Title Cn
Title En
Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea
Bilingual Status
semi_complete